Cardiovascular Outcomes in Framingham Participants With Diabetes The Importance of Blood Pressure

被引:207
|
作者
Chen, Guanmin [1 ]
McAlister, Finlay A. [2 ,3 ]
Walker, Robin L. [1 ]
Hemmelgarn, Brenda R. [1 ]
Campbell, Norm R. C. [1 ]
机构
[1] Univ Calgary, Dept Med, Calgary, AB, Canada
[2] Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada
[3] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada
基金
加拿大健康研究院;
关键词
diabetes mellitus; hypertension; Framingham; population-attributable risk; TERM-FOLLOW-UP; RISK; MELLITUS; EVENTS; DISEASE; HYPERTENSION; MORTALITY; ADULTS;
D O I
10.1161/HYPERTENSIONAHA.110.162446
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We designed this study to explore to what extent the excess risk of cardiovascular events in diabetic individuals is attributable to hypertension. We retrospectively analyzed prospectively collected data from the Framingham original and offspring cohorts. Of the 1145 Framingham subjects newly diagnosed with diabetes mellitus who did not have a previous history of cardiovascular events, 663 (58%) had hypertension at the time that diabetes mellitus was diagnosed. During 4154 person-years of follow-up, 125 died, and 204 experienced a cardiovascular event. Framingham participants with hypertension at the time of diabetes mellitus diagnosis exhibited higher rates of all-cause mortality (32 versus 20 per 1000 person-years; P<0.001) and cardiovascular events (52 versus 31 per 1000 person-years; P<0.001) compared with normotensive subjects with diabetes mellitus. After adjustment for demographic and clinical covariates, hypertension was associated with a 72% increase in the risk of all-cause death and a 57% increase in the risk of any cardiovascular event in individuals with diabetes mellitus. The population-attributable risk from hypertension in individuals with diabetes mellitus was 30% for all-cause death and 25% for any cardiovascular event (increasing to 44% and 41%, respectively, if the 110 normotensive subjects who developed hypertension during follow-up were excluded from the analysis). In comparison, after adjustment for concurrent hypertension, the population-attributable risk from diabetes mellitus in Framingham subjects was 7% for all-cause mortality and 9% for any cardiovascular disease event. Although diabetes mellitus is associated with increased risks of death and cardiovascular events in Framingham subjects, much of this excess risk is attributable to coexistent hypertension. (Hypertension. 2011;57:891-897.) . Online Data Supplement
引用
收藏
页码:891 / U65
页数:16
相关论文
共 50 条
  • [21] Baseline Diastolic Blood Pressure and Cardiovascular Outcomes in SPRINT Participants with Chronic Kidney Disease
    Chang, Tara, I
    Wei, Guo
    Boucher, Robert
    Kramer, Holly
    Chertow, Glenn M.
    Cheung, Alfred K.
    Greene, Tom
    Whelton, Paul K.
    Beddhu, Srinivasan
    KIDNEY360, 2020, 1 (05): : 368 - 375
  • [22] Cardiovascular Outcomes in Action to Control Cardiovascular Risk in Diabetes: Impact of Blood Pressure Level and Presence of Kidney Disease
    Papademetriou, Vasilios
    Zaheer, Misbah
    Doumas, Michael
    Lovato, Laura
    Applegate, William B.
    Tsioufis, Costas
    Mottle, Amy
    Punthakee, Zubin
    Cushman, William C.
    AMERICAN JOURNAL OF NEPHROLOGY, 2016, 43 (04) : 271 - 280
  • [23] Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk
    Boehm, Michael
    Schumacher, Helmut
    Teo, Koon K.
    Lonn, Eva M.
    Mahfoud, Felix
    Mann, Johannes F. E.
    Mancia, Giuseppe
    Redon, Josep
    Schmieder, Roland E.
    Marx, Nikolaus
    Sliwa, Karen
    Weber, Michael A.
    Williams, Bryan
    Yusuf, Salim
    EUROPEAN HEART JOURNAL, 2019, 40 (25) : 2032 - 2043
  • [24] Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus
    Rawshani, Aidin
    Rawshani, Araz
    Sattar, Naveed
    Franzen, Stefan
    McGuire, Darren K.
    Eliasson, Bjorn
    Svensson, Ann-Marie
    Zethelius, Bjorn
    Miftaraj, Mervete
    Rosengren, Annika
    Gudbjornsdottir, Soffia
    CIRCULATION, 2019, 139 (16) : 1900 - 1912
  • [25] Longer time in blood pressure target range improves cardiovascular outcomes among patients with Type 2 diabetes: A secondary analysis of a randomized clinical trial
    Chen, KangYu
    Wu, Zhenqiang
    Shi, Rui
    Wang, Qi
    Yuan, Xiaodan
    Wu, Guohong
    Shi, Guoshuai
    Li, Chao
    Chen, Tao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 198
  • [26] Long-Term Variability of Blood Pressure, Cardiovascular Outcomes, and Mortality: The Look AHEAD Study
    Kaze, Arnaud D.
    Santhanam, Prasanna
    Erqou, Sebhat
    Yuyun, Matthew
    Bertoni, Alain G.
    Ahima, Rexford S.
    Echouffo-Tcheugui, Justin B.
    AMERICAN JOURNAL OF HYPERTENSION, 2021, 34 (07) : 689 - 697
  • [27] Blood Pressure and Cardiovascular Disease: Tracing the Steps From Framingham
    Turnbull, Fiona
    Kengne, Andre Pascal
    MacMahon, Stephen
    PROGRESS IN CARDIOVASCULAR DISEASES, 2010, 53 (01) : 39 - 44
  • [28] Blood Pressure and the Risk of Developing Diabetes in African Americans and Whites ARIC, CARDIA, and the Framingham Heart Study
    Wei, Gina S.
    Coady, Sean A.
    Goff, David C., Jr.
    Brancati, Frederick L.
    Levy, Daniel
    Selvin, Elizabeth
    Vasan, Ramachandran S.
    Fox, Caroline S.
    DIABETES CARE, 2011, 34 (04) : 873 - 879
  • [29] Association of postexercise blood pressure with cardiovascular outcomes and mortality: The CARDIA study
    Wang, Jia-Jie
    Zheng, Zhichao
    Zhang, Ying
    JOURNAL OF CLINICAL HYPERTENSION, 2024, 26 (05) : 491 - 499
  • [30] Initial hospital pulse pressure and cardiovascular outcomes in acute coronary syndrome
    El-Menyar, Ayman
    Zubaid, Mohammad
    Almahmeed, Wael
    Alanbaei, Muath
    Rashed, Wafa
    Al Qahtani, Awad
    Singh, Rajvir
    Zubair, Shahid
    Al Suwaidi, Jassim
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2011, 104 (8-9) : 435 - 443